Award Overview
Takeda Pharmaceuticals Czech Republic s.r.o. was awarded Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Vedolizumab_VII. by Institut klinické a experimentální medicíny in Czech Republic, tracked by GlobalGov. The award is valued at $4.8M. It was awarded on April 27, 2026. Classification: NAICS 33652300. Full award details and the issuing agency are below.
See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.
Start FreeAward Details
| Awardee | Takeda Pharmaceuticals Czech Republic s.r.o. |
|---|---|
| Awardee country | Czech Republic |
| Awarding agency | Institut klinické a experimentální medicíny |
| Country | Czech Republic |
| Award value | $4.8M |
| Award date | April 27, 2026 |
| NAICS | 33652300 |
| Official source | View original award record |
| Last verified | September 1, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Track every Czech Republic contract award and the opportunities behind them. Free for 14 days.
Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required